Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision tag on the page changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA banner about government funding status and NIH operations was added, with links to cc.nih.gov and opm.gov. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data). Introduced a new Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference0.1%

- Check62 days agoChange DetectedOnly a minor site revision update is visible, with Revision: v3.3.4 added and Revision: v3.3.3 removed; this change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section has been refreshed with numerous new site entries across the U.S. and internationally. The prior location listings have been removed in favor of the updated, expanded site list.SummaryDifference2%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.